Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completed

Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden

NCT04708626
unknown

GFAP Auto-immunity : a French Cohort Study

NCT04463550
unknown

Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis

NCT04339127

Clinical Trials (3)

Showing 3 of 3 trials
NCT04708626

Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden

Completed
NCT04463550

GFAP Auto-immunity : a French Cohort Study

Unknown
NCT04339127

Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3